Skip to main content
Premium Trial:

Request an Annual Quote

Torus Biosystems Completes $25M Series A Financing Round

NEW YORK – Torus Biosystems announced on Wednesday the completion of a $25 million Series A financing round. The firm will use the funding to accelerate commercialization of its point-of-care syndromic testing system, Synestia.

The financing round was led by Northpond Ventures. Prior investors, including Torus cofounder David Walt, also participated in the round. Northpond's director Adam Wieschhaus will join Torus' board.

Synestia is a sample-to-answer molecular diagnostic system that can detect multiple targets in 30 minutes using proprietary probes, nanoarrays, and convection qPCR. The firm is developing assays for the identification of infectious disease pathogens, host immune response, and drug resistance.

"Our goal is to provide the healthcare system with a new gold standard in syndromic testing, including a broad menu of tests on a compact, portable device that delivers rapid results when providers need them to make the best clinical decisions for their patients," said Shawn Marcell, Torus' cofounder and CEO, in a statement.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.